Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers

NCT01926626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Dependence

Interventions

DRUG: Nicotine Patch
DRUG: Moclobemide

Sponsor

Jed E. Rose

Collaborators

[object Object]
[object Object]